Model
Edge
Intercept Pharmaceuticals, Inc.
0001705295
Filing type
4
Filing date
Jan 3, 2022
Updated
Jan 4, 2022 ยท 9:17 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership